AMBEY

Ambey Laboratories Share Price

₹67.2
-3.2 (-4.55%)
18 September, 2024 02:40 BSE: NSE: AMBEY ISIN: INE0M3I01029

Start SIP in Ambey Laboratories

Start SIP

Ambey Laboratories Performance

Day Range

  • Low 66
  • High 70
₹ 67

52 Week Range

  • Low 61
  • High 97
₹ 67
  • Open Price70
  • Previous Close70
  • Volume98000

Ambey Laboratories Chart

  • Over 1 Month -2.25%
  • Over 3 Month -1.18%
  • Over 6 Month -1.18%
  • Over 1 Year -1.18%

Ambey Laboratories Key Statistics

P/E Ratio
PEG Ratio
Market Cap Cr
Price to Book Ratio 12.8
EPS 3.2
Dividend 0
Relative Strength Index 36.01
Money Flow Index 23.72
MACD Signal -1.49
Average True Range 4.17

Ambey Laboratories Investment Rating

  • Master Rating:
  • Ambey Laboratories Ltd has an operating revenue of Rs. 271.16 Cr. on a trailing 12-month basis. An annual revenue growth of 26% is outstanding, Pre-tax margin of 6% is okay, ROE of 34% is exceptional. The company has a debt to equity of 97%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 69 which is a FAIR score but needs to improve its earnings, a RS Rating of 4 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 57 indicates it belongs to a fair industry group of Diversified Operations and a Master Score of D is close to being the worst. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Ambey Laboratories Financials
IndicatorMar 2023
Total Revenue Annual Cr 107
Operating Expenses Annual Cr 96
Operating Profit Annual in Cr 8
Depreciation Cr 3
Interest Annual Cr 2
Tax Annual Cr 2
Net Profit Annual Cr 5
IndicatorMar 2023
Cash from Operating Activity Annual Cr 9
Cash from Investing Activity Annual Cr -3
Cash from Financing Annual Activity Cr -6
Net Cash Flow Annual Cr 0
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 24
Fixed Assets Annual Cr 25
Total Non Current Assets Annual Cr 30
Total Current Assets Annual Cr 28
Total Assets Annual Cr 58
IndicatorMar 2023
Book Value Per Share Annual Rs 133
ROE Annual % 35
ROCE Annual % 22
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 11
IndicatorMar 2023
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual -
EBDIT Annual Margin %

Ambey Laboratories Technicals

EMA & SMA

Current Price
₹67.2
-3.2 (-4.55%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 9
  • 20 Day
  • ₹73.01
  • 50 Day
  • 100 Day
  • 200 Day
  • 20 Day
  • ₹74.58
  • 50 Day
  • 100 Day
  • 200 Day

Ambey Laboratories Resistance and Support

PIVOT
₹67.87
Resistance
First Resistance 69.73
Second Resistance 72.27
Third Resistance 74.13
RSI 36.01
MFI 23.72
MACD Single Line -1.49
MACD -1.73
Support
First Support 65.33
Second Support 63.47
Third Supoort 60.93

Ambey Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 98,000 8,199,660 83.67
Week 50,800 3,679,952 72.44
1 Month 125,818 8,963,287 71.24
6 Month 105,252 8,543,307 81.17

Ambey Laboratories Result Highlights

Ambey Laboratories Synopsis

NSE-Diversified Operations

Ambey Laboratories belongs to the Industry of Agro Chemicals/Pesticides. Company’s Total Operating Revenue is Rs. 104.82 Cr. and Equity Capital is Rs. 17.75 Cr. for the Year ended 31/03/2023. Ambey Laboratories Ltd. is a Public Limited Listed company incorporated on 20/03/1985 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is U74899DL1985PLC020490 and registration number is 020490.
Market Cap 177
Sales 105
Shares in Float 0.75
No of funds
Yield
Book Value 0.96
U/D Vol ratio 0.6
LTDebt / Equity 97
Alpha -0.53
Beta 0.97

Ambey Laboratories Shareholding Pattern

Owner Name

Ambey Laboratories Management

Name Designation
Mrs. Sarina Gupta Whole Time Director
Mrs. Rishita Gupta Non Executive Director
Mr. Sandeep Bansal Non Executive Director
Mr. Abdul Quadir Independent Director
Ms. Roni Soni Independent Director
Mr. Sarvar Alam Chief Financial Officer
Ms. Rimple Sarin Co. Secretary & Compl. Officer

Ambey Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Ambey Laboratories MF Shareholding

Name Amount(cr)

Ambey Laboratories FAQs

What is Share Price of Ambey Laboratories ?

Ambey Laboratories share price is ₹67 As on 18 September, 2024 | 02:26

What is the Market Cap of Ambey Laboratories ?

The Market Cap of Ambey Laboratories is ₹167.6 Cr As on 18 September, 2024 | 02:26

What is the P/E ratio of Ambey Laboratories ?

The P/E ratio of Ambey Laboratories is As on 18 September, 2024 | 02:26

What is the PB ratio of Ambey Laboratories ?

The PB ratio of Ambey Laboratories is 12.8 As on 18 September, 2024 | 02:26

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form